The most comprehensive AI-based drug discovery platform for developing rare disease treatments
Our AI platform Healnet enables highly parallel and large-scale rare disease drug discovery, significantly reducing time, cost and risk.
Healnet was built and is maintained using a variety of machine learning methods applied to a wide range of data types from both publicly available and exclusive sources. These include scientific literature, patents, clinical trials, disease symptoms, drug targets, multi-omics data and chemical structures.
Healnet is enhanced by a team of rare disease experts, patient advocates, pharmacologists, clinicians and scientific curators.